[1]
T. Lawen, K. Masoumi-Ravandi, R. A. Rendon, L. Connor, and R. J. Mason, “A comparison of the sarcopenic effect of androgen receptor-axistargeted agents vs. androgen deprivation alone in patients with metastatic prostate cancer”, CUAJ, vol. 17, no. 8, pp. 274–9, May 2023.